LUCENTIS

Swiss trademark · 518904 · Word mark · In force

Register entry

Registration number
518904
Application number
04744/2003
Status
In force
Type
Word mark
Filed
Sep 15, 2003
Registered
Feb 25, 2004
Published
Mar 10, 2004
Protected until
Sep 15, 2033
Priority
16.04.2003 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le traitement des maladies et troubles cardiovasculaires, des maladies et troubles oncologiques, des maladies et troubles immunitaires, des maladies et troubles de l'angiogenèse, des maladies et troubles oculaires, des maladies et troubles inflammatoires.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 4, 2023

    Renewed

    Published in Swissreg on 04.05.2023

  2. Feb 20, 2020

    Licensee entered

    Exclusive licensee
    Novartis Pharma AG, Lichtstrasse 35, 4002 Basel

    Published in Swissreg on 20.02.2020

  3. Jan 16, 2013

    Renewed

    Published in Swissreg on 16.01.2013

  4. Mar 10, 2011

    Agent entered

    Representative
    Katzarov S.A., 19, rue des Epinettes, 1227 Genève → F. Hoffmann-La Roche AG, Corporate Trademarks, 4002 Basel

    Published in Swissreg on 10.03.2011

  5. Mar 10, 2004

    Registered

    Published in the SOGC no. 48 of 10.03.2004

Parties

Holder

GENENTECH, INC.

1 DNA Way, South San Francisco (CA 94080), US

Agent

F. Hoffmann-La Roche AG

Corporate Trademarks, 4002 Basel

Exclusive licensee

Novartis Pharma AG

Lichtstrasse 35, 4002 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.